COEP
Coeptis Therapeutics·NASDAQ
--
--(--)
--
--(--)
COEP Filings
Filing Date
Form Description
Form Type
2026-02-04
Form 8-K - Current report
Key Events
2026-02-04 · Key Events
Form 8-K - Current report
2026-01-30
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-30 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-29
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-29 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-29
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2026-01-29 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2026-01-16
Form 8-K - Current report
Key Events
2026-01-16 · Key Events
Form 8-K - Current report
2026-01-05
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-05 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-29
Form EFFECT - Notice of Effectiveness
2025-12-29 ·
Form EFFECT - Notice of Effectiveness
2025-12-22
Form S-4/A - Registration of securities, business combinations: [Amend]
Key Events
2025-12-22 · Key Events
Form S-4/A - Registration of securities, business combinations: [Amend]
2025-12-15
Form 144 - Report of proposed sale of securities
Ownership
2025-12-15 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-10
Form S-4/A - Registration of securities, business combinations: [Amend]
Key Events
2025-12-10 · Key Events
Form S-4/A - Registration of securities, business combinations: [Amend]
